Target intelligence / Profile preview

Glutaredoxin pseudogene 3 (GLRXP3)

Target: GLRXP3
Molecular classification: Other (pseudogene)

Overview

Glutaredoxin pseudogene 3 (GLRXP3) is a non-functional pseudogene, meaning it is a genomic sequence similar to the protein-coding glutaredoxin genes but does not encode a functional protein. There is no evidence that GLRXP3 has any enzymatic activity, biological function, or role as a target for therapeutic intervention. Pseudogenes like GLRXP3 are remnants of evolutionarily related protein-coding genes (in this case, related to the glutaredoxin family), but with accumulating mutations and/or lack of necessary regulatory elements, they do not produce a functional protein product[1][4]. There is no literature suggesting any use as a drug target, biomarker, or the presence of disease relevance for GLRXP3 specifically.

Other names: GRX pseudogene 3glutaredoxin-related pseudogene 3

Beyond the preview

Go deeper on Glutaredoxin pseudogene 3 (GLRXP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutaredoxin pseudogene 3 (GLRXP3).

Explore the full profile